David Spencer

David Spencer, MD, PhD is an Associate Professor of Medicine, Pathology, and Immunology, and the Medical Director of the McDonnel Genome Institute Clinical Sequencing Lab at Washington University in St. Louis. He is leading the SCGE Phase 2 U01 project titled “Genome sequencing for evaluating the efficacy, specificity, and safety of human genome editing“.

In this interview, Dr. Spencer discusses his research on genome sequencing assays and how these assays and technologies can help test and improve the safety and effectiveness of genome editing therapies.